Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Axcel in connection with the acquisition of Progrits, a leading software company in vertical software and information services
Mandate

Vinge advises Axcel in connection with the acquisition of Progrits, a leading software company in vertical software and information services

June 14, 2023 M&A EU, Competition and Regulatory Commercial Agreements Employment and Benefits Banking and Finance Intellectual Property IT, Telecommunications and Outsourcing Data protection and processing of personal data

Progrits consists of ten businesses that develop specialised solutions within transport and logistics, vehicle digital solutions and integrated e-commerce. The B2B software company simplifies and automates customer information handling and workflows for approximately 5,000 Nordic and international customers.

The acquisition is subject to approval from applicable competition authority.

Vinge’s team consisted of Christina Kokko, Johanna Wiberg, Viktor Lennartsson, Nando Basic and Josef Groow (M&A), Mathilda Persson and Alva Skott (Commercial Agreements), August Ahlin (Banking and Financing), Madelene Andersson (Real Estate), Julia Löfqvist (Compliance), Tove Hallbäck (Employment), Lisa Hörnqvist (IT and GDPR), Arvid Axelryd and Felizia Wiker (Intellectual Property), Sebastian Örndahl, Victoria Fredén and Hampus Peterson (Merger filing) and Ellinore Boström Andersson (Project Assistant).

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026